Pandemic Causing Increased Anxiety Among Patients With Multiple Sclerosis
The COVID-19 pandemic is having an impact on the psychological health of patients with relapsing-remitting multiple sclerosis.
The COVID-19 pandemic is having an impact on the psychological health of patients with relapsing-remitting multiple sclerosis.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
Reduced circadian rhythmicity is associated with an increased risk for incident Parkinson disease.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
In a randomized clinical trial of patients with prior stroke, remotely administered CBT was associated with a greater reduction in anxiety symptoms than relaxation therapy.
A third of patients presented with an altered mental state, including 9 patients with unspecified encephalopathy, 7 with encephalitis, and 23 fulfilling the clinical definition for psychiatric diagnoses.
The researchers concluded that risk for MCI was associated with neurodegeneration and neuropsychiatric symptoms among adults aged 50 years and older, and that an abnormal FDG-PET was a stronger driving force for cognitive decline.
Rhythmic movement disorder is a rare motor disorder that results in frequent night sleep disturbances.
The researchers concluded that effective monitoring of psychiatric and cognitive comorbidities was essential for patients with MS and updated treatment options applicable to the conditions of the viral pandemic are a necessity.
Researchers sought to determine the relationship between neuroimaging markers and other clinical characteristics with mild parkinsonian signs in older adults.